FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890884829> ?p ?o ?g. }

• W2890884829 endingPage "546" @default.
• W2890884829 startingPage "543" @default.
• W2890884829 abstract "Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are structurally novel, bioactive lipids that are synthesized in humans, animals, and plants and that have beneficial metabolic and anti-inflammatory effects (Kuda et al., 2016Kuda O. Brezinova M. Rombaldova M. Slavikova B. Posta M. Beier P. Janovska P. Veleba J. Kopecky Jr., J. Kudova E. et al.Docosahexaenoic acid-derived fatty acid esters of hydroxy fatty acids (FAHFAs) with anti-inflammatory properties.Diabetes. 2016; 65: 2580-2590Crossref PubMed Scopus (112) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar, Zhu et al., 2018Zhu Q.F. Yan J.W. Zhang T.Y. Xiao H.M. Feng Y.Q. Comprehensive screening and identification of fatty acid esters of hydroxy fatty acids in plant tissues by chemical isotope labeling-assisted liquid chromatography-mass spectrometry.Anal. Chem. 2018; 90: 10056-10063Crossref PubMed Scopus (60) Google Scholar). An in silico analysis predicted that >1,000 FAHFAs could exist in nature (Ma et al., 2015Ma Y. Kind T. Vaniya A. Gennity I. Fahrmann J.F. Fiehn O. An in silico MS/MS library for automatic annotation of novel FAHFA lipids.J. Cheminform. 2015; 7: 53Crossref PubMed Scopus (56) Google Scholar), and >20 FAHFA families have been identified in mammalian tissues (Kuda et al., 2016Kuda O. Brezinova M. Rombaldova M. Slavikova B. Posta M. Beier P. Janovska P. Veleba J. Kopecky Jr., J. Kudova E. et al.Docosahexaenoic acid-derived fatty acid esters of hydroxy fatty acids (FAHFAs) with anti-inflammatory properties.Diabetes. 2016; 65: 2580-2590Crossref PubMed Scopus (112) Google Scholar, Kuda et al., 2018Kuda O. Brezinova M. Silhavy J. Landa V. Zidek V. Dodia C. Kreuchwig F. Vrbacky M. Balas L. Durand T. et al.Nrf2-mediated antioxidant defense and peroxiredoxin 6 are linked to biosynthesis of palmitic acid ester of 9-hydroxystearic acid.Diabetes. 2018; 67: 1190-1199Crossref PubMed Scopus (44) Google Scholar, Ma et al., 2015Ma Y. Kind T. Vaniya A. Gennity I. Fahrmann J.F. Fiehn O. An in silico MS/MS library for automatic annotation of novel FAHFA lipids.J. Cheminform. 2015; 7: 53Crossref PubMed Scopus (56) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar), with many additional families in plants (Zhu et al., 2018Zhu Q.F. Yan J.W. Zhang T.Y. Xiao H.M. Feng Y.Q. Comprehensive screening and identification of fatty acid esters of hydroxy fatty acids in plant tissues by chemical isotope labeling-assisted liquid chromatography-mass spectrometry.Anal. Chem. 2018; 90: 10056-10063Crossref PubMed Scopus (60) Google Scholar). These families differ by their acyl-chain composition and consist of multiple isomers distinguished by the position of the ester bond between acyl chains. Palmitic acid esters of hydroxy stearic acids (PAHSAs) have been studied most extensively. Levels of multiple PAHSA isomers are reduced in serum and subcutaneous adipose tissue of insulin-resistant mice and humans, and serum PAHSA levels correlate highly with insulin sensitivity in humans (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar). A single oral dose of 5-PAHSA or 9-PAHSA improves glucose tolerance in aged, glucose-intolerant chow-fed and high-fat diet (HFD)-fed mice (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar), whereas chronic subcutaneous PAHSA treatment improves both insulin sensitivity and glucose tolerance in chow-fed and HFD-fed mice (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). The anti-inflammatory effects of PAHSAs are seen in mouse models of insulin resistance (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar, Vijayakumar et al., 2017Vijayakumar A. Aryal P. Wen J. Syed I. Vazirani R.P. Moraes-Vieira P.M. Camporez J.P. Gallop M.R. Perry R.J. Peroni O.D. et al.Absence of carbohydrate response element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport.Cell Rep. 2017; 21: 1021-1035Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar), colitis (Lee et al., 2016Lee J. Moraes-Vieira P.M. Castoldi A. Aryal P. Yee E.U. Vickers C. Parnas O. Donaldson C.J. Saghatelian A. Kahn B.B. Branched fatty acid esters of hydroxy fatty acids (FAHFAs) protect against colitis by regulating gut innate and adaptive immune responses.J. Biol. Chem. 2016; 291: 22207-22217Crossref PubMed Scopus (81) Google Scholar), and type 1 diabetes (Syed et al., 2017Syed I. Mohan J.F. Moraes-Vieria P.M. Vijayakumar A. De Celis M.F.R. Nelson A.T. Siegel D. Saghatelian A. Mathis D. Kahn B.B. PAHSAs reduce type 1 diabetes incidence in nonobese diabetic (NOD) mice through anti-inflammatory effects and direct protection against cytokine-induced islet β-cell death.Diabetes. 2017; 66: A87PubMed Google Scholar). Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar recently challenged the finding that PAHSAs have beneficial metabolic effects. We appreciate the attempt to corroborate our findings as reproducibility of results by different laboratories is critical. While these different results may be perceived as a reproducibility issue, numerous methodological differences, some of which were mentioned by Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar in their “limitations” section, can explain why Pflimlin et al.’s experiments did not detect anti-diabetic effects (Tables S1 and S2). None of the experiments in Pflimlin et al. repeated the protocols used in any previous PAHSA/FAHFA papers. Choice of vehicles for in vivo studies. Pflimlin et al. used olive oil, which contains many bioactive, metabolically beneficial molecules including omega-3 and -6 fatty acids, tocopherols, polyphenols, hydroxytyrosols, flavones, lignans (Guasch-Ferré et al., 2017Guasch-Ferré M. Merino J. Sun Q. Fitó M. Salas-Salvadó J. Dietary polyphenols, Mediterranean diet, prediabetes, and type 2 diabetes: a narrative review of the evidence.Oxid. Med. Cell. Longev. 2017; 2017: 6723931Crossref PubMed Scopus (168) Google Scholar), and FAHFAs (Figure S1A). Hence, olive oil is not an inert vehicle. Figures S1B–S1D shows striking effects of olive oil itself to improve oral glucose tolerance tests (OGTTs) in HFD-fed mice compared to no effects of PEG400/Tween80 used in other studies. We recapitulated the conditions used by Pflimlin et al. (same lard HFD, volume of vehicle, and glucose concentration for OGTT) and found that olive oil markedly reduces glucose excursion (Figure S1B), so it is similar to that of mice on a low-fat diet (LFD) (Figure S1C). In fact, the increase in glycemia at 8 min is even lower than in LFD-fed mice. In contrast, in mice on the same lard HFD, the PEG400/Tween80 vehicle has no effect on glucose tolerance with the conditions used in Yore et al. (1 g/kg glucose) (Figure S1D). With the marked effect of olive oil itself, one would not expect an additional effect of PAHSAs. The beneficial effects of olive oil may result from signaling effects of the constituent molecules, some of which are known to stimulate GLP-1 release (Rocca et al., 2001Rocca A.S. LaGreca J. Kalitsky J. Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.Endocrinology. 2001; 142: 1148-1155Crossref PubMed Scopus (0) Google Scholar) and from delayed glucose absorption. In our work, we rigorously tested many vehicles including olive oil and DMSO to study PAHSA biology and eliminated olive oil due to its independent biological effects. PEG400/Tween80 gavage had no effect when 1 g/kg glucose was administered (Figure S1D), as in Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar, although it can affect glycemic excursion with higher glucose doses (unpublished data). For one OGTT, Pflimlin et al. used the PEG400/Tween80 vehicle (Figure 3D in Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar). However, it was used with the lard diet on which the mice had not developed glucose intolerance. There is no LFD control for the lard diet, but the glucose values in HFD vehicle mice in Figures 3A and 3D in Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar appear similar to the values for LFD vehicle in their Figure 2A. Hence, it is difficult to interpret these data. High-fat diets. Pflimlin et al. studied PAHSA effects in mice on several HFDs. Ideally, if PAHSAs are beneficial, the effects would be present on more than one diet, but not necessarily with a single PAHSA dose in insulin-sensitive mice. Although we showed beneficial effects of constant PAHSA infusion by subcutaneous minipump for 9–13 days (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar) or daily gavage for 12 days (unpublished data) in chow-fed mice, we have not published effects of a single dose of PAHSAs in young, lean chow-fed mice with normal glucose tolerance and insulin sensitivity. To that point, in the study by Pflimlin et al., there is no evidence of glucose intolerance in their vehicle-treated HFD mice, and data indicating insulin resistance are insufficient, consisting only of elevated insulin levels 4.5 hr after food removal with no statistical difference reported for insulin tolerance test (ITT) (Figure 3B in Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar). In fact, Figure 2B in Pflimlin et al. indicates that glucose tolerance is not different between vehicle-treated LFD and HFD mice using the hydrogenated vegetable diet, in contrast to the glucose intolerance and insulin resistance seen with this same HFD in Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar and Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar. In addition, glucose tolerance in mice on the high-fat coconut oil diet (Figure S2A in Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar) is not different from that in mice on the corresponding LFD. The olive oil vehicle may be improving the glucose tolerance, but nevertheless we would not expect an additive effect of PAHSAs and olive oil. In one experiment, Pflimlin et al. gavaged mice daily with PAHSAs for 6 days and saw no effects on OGTT (Figure 3E in Pflimlin et al., 2018Pflimlin E. Bielohuby M. Korn M. Breitschopf K. Löhn M. Wohlfart P. Konkar A. Podeschwa M. Bärenz F. Pfenninger A. et al.Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.Cell Metab. 2018; 28: 217-227.e13Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar). This is likely due to the fact that both vehicle- and PAHSA-treated mice received daily gavage with olive oil, which has been shown to improve glucose homeostasis and GLP1 secretion even with short-term treatment (Rocca et al., 2001Rocca A.S. LaGreca J. Kalitsky J. Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.Endocrinology. 2001; 142: 1148-1155Crossref PubMed Scopus (0) Google Scholar). In addition, olive oil was used as the vehicle in the OGTT, which would mask the effects of PAHSAs. Glucose doses for OGTT. Pflimlin et al. used 2 g glucose/kg body weight and Yore et al. used 1 g/kg. This affects excursion on OGTT, which is critical for detecting improvement with therapeutic agents. We tested both glucose concentrations and found that PAHSA effects in our vehicle (PEG400/Tween80) were more pronounced with 1 g/kg. Glucose-stimulated insulin and GLP-1 secretion. Pflimlin et al. reported no effect of PAHSAs on glucose-stimulated insulin or GLP-1 secretion in HFD-fed mice. This may be a result of the olive oil vehicle stimulating GLP-1 secretion (Rocca et al., 2001Rocca A.S. LaGreca J. Kalitsky J. Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.Endocrinology. 2001; 142: 1148-1155Crossref PubMed Scopus (0) Google Scholar), resulting in increased insulin secretion so there is no further effect of PAHSAs. However, it is worth noting that we did not report an effect of PAHSAs on GLP-1 or insulin secretion in HFD-fed mice with either acute or chronic treatments. We reported the effect of a single PAHSA dose on GLP-1 and insulin secretion only in aged, glucose-intolerant chow-fed mice (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar) and the effect of continuous PAHSA infusion by mini pump in ∼4-month-old chow-fed mice (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). So the data of Pflimlin et al. in HFD-fed mice do not differ from our data. Our results indicate that the beneficial metabolic effects of PAHSAs in HFD mice result primarily from improved insulin sensitivity (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). PAHSA concentrations achieved with treatment. We designed our studies to achieve a 1.5- to 3-fold elevation in serum PAHSA levels in chow-fed mice since this is the range of changes in PAHSA levels in tissues or serum with altered nutritional and metabolic states (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar). Since HFD mice have lower PAHSA levels, we sought to restore levels or increase them modestly above chow levels (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). However, in their 6-day PAHSA treatment study, Pflimlin et al. achieved massive elevations in serum PAHSA levels (5-PAHSA, 477-fold; 9-PAHSA, >87-fold compared to olive oil alone; Table S2 in Pflimlin et al. and Table S2 in this letter). These massive elevations could engage signaling pathways that are not usually affected by PAHSAs, saturate receptors preventing responses to other ligands, or have other off-target effects. The possibility of saturating receptors for PAHSAs was mentioned by Pflimlin et al., although they thought it was unlikely. In addition, the accuracy of the PAHSA levels is questionable. See the liquid chromatography-mass spectrometry (LC-MS) section below. In vitro experiments. Numerous methodological issues are also likely to contribute to the different results in cultured cell systems (Table S1). For example, we found that PAHSAs augment insulin-stimulated glucose transport in 3T3-L1 adipocytes and freshly isolated mouse adipocytes using multiple insulin concentrations (Vijayakumar et al., 2017Vijayakumar A. Aryal P. Wen J. Syed I. Vazirani R.P. Moraes-Vieira P.M. Camporez J.P. Gallop M.R. Perry R.J. Peroni O.D. et al.Absence of carbohydrate response element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport.Cell Rep. 2017; 21: 1021-1035Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar). In contrast, Pflimlin et al. did not find PAHSA effects on glucose transport in human SVF-derived adipocytes or a genetically modified L6 myocyte cell line. Critically, Pflimlin et al. studied the effects of PAHSAs on glucose transport in human cells only with maximal insulin concentrations, conditions in which it would be impossible to detect the insulin-sensitizing effects of PAHSAs. In the study using human adipocytes, the lowest insulin concentration used by Pflimlin et al. (1 nM) stimulated glucose transport to the same degree as the highest insulin dose (100 nM). Therefore, under the conditions used by Pflimlin et al., 1 nM insulin is maximally stimulating in their human adipocyte culture system. Thus, no conclusions can be drawn from their in vitro studies regarding whether PAHSAs augment insulin sensitivity. Differences in the incubation time with PAHSAs could also contribute to the different results, although we have seen effects with incubation times ranging from 2.5 hr (Vijayakumar et al., 2017Vijayakumar A. Aryal P. Wen J. Syed I. Vazirani R.P. Moraes-Vieira P.M. Camporez J.P. Gallop M.R. Perry R.J. Peroni O.D. et al.Absence of carbohydrate response element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport.Cell Rep. 2017; 21: 1021-1035Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar) to 6 days (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar) (Table S1). Regarding the inability of Pflimlin et al. to detect augmentation of glucose-stimulated insulin secretion (GSIS) by PAHSAs in pancreatic islets, a recent paper corroborated our results using a completely different methodology, i.e., microfluidics (Bandak et al., 2018Bandak B. Yi L. Roper M.G. Microfluidic-enabled quantitative measurements of insulin release dynamics from single islets of Langerhans in response to 5-palmitic acid hydroxy stearic acid.Lab Chip. 2018; 15https://doi.org/10.1039/c8lc00624eCrossref Scopus (35) Google Scholar). That paper showed that in human islets from both healthy donors and type 2 diabetic donors and in murine islets, 5-PAHSA increased the total amount of GSIS and also improved the dynamic insulin release profiles as indicated by more pronounced insulin oscillations. The absence of PAHSA effects on GSIS in Pflimlin et al. may result from substantial differences in the study protocols compared to Yore et al. and Syed et al. (Table S1). For example, we used 100 human islets/incubation condition while Pflimlin et al. used only 3 islets/condition. Also, no glucose was present in the preincubation buffer in our studies, whereas glucose was present in the studies by Pflimlin et al. This could affect the subsequent response to glucose. For studies of GLP-1 secretion, different cell lines were used that have a different constellation of fatty acid receptors. Assay conditions are also critical since PAHSAs are extremely hydrophobic and need to be maintained at ≥37°C to remain in solution. General issues. Other important differences (see Table S1) include (1) the number of mice used for studies of acute PAHSA effects (12–14 per group in our studies; 6 per group in Pflimlin et al.); (2) different mouse suppliers, which can result in different severity of insulin resistance even among mice from the same strain (Ussar et al., 2015Ussar S. Griffin N.W. Bezy O. Fujisaka S. Vienberg S. Softic S. Deng L. Bry L. Gordon J.I. Kahn C.R. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome.Cell Metab. 2015; 22: 516-530Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar); and (3) different treatment duration (for chronic treatment, 4.5–5 months in our studies; 6 days in Pflimlin et al.). Our data also show greater PAHSA effects in a mixed genetic background (Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar), indicating the effects are not limited to one strain. LC-MS. The LC-MS protocol used by Pflimlin et al. to measure PAHSA levels did not recapitulate any of the protocols published by three independent groups (Brezinova et al., 2018Brezinova M. Kuda O. Hansikova J. Rombaldova M. Balas L. Bardova K. Durand T. Rossmeisl M. Cerna M. Stranak Z. Kopecky J. Levels of palmitic acid ester of hydroxystearic acid (PAHSA) are reduced in the breast milk of obese mothers.Biochim. Biophys. Acta. 2018; 1863: 126-131Crossref PubMed Scopus (44) Google Scholar, Kolar et al., 2018Kolar M.J. Nelson A.T. Chang T. Ertunc M.E. Christy M.P. Ohlsson L. Härröd M. Kahn B.B. Siegel D. Saghatelian A. Faster protocol for endogenous fatty acid esters of hydroxy fatty acid (FAHFA) measurements.Anal. Chem. 2018; 90: 5358-5365Crossref PubMed Scopus (33) Google Scholar, Kuda et al., 2018Kuda O. Brezinova M. Silhavy J. Landa V. Zidek V. Dodia C. Kreuchwig F. Vrbacky M. Balas L. Durand T. et al.Nrf2-mediated antioxidant defense and peroxiredoxin 6 are linked to biosynthesis of palmitic acid ester of 9-hydroxystearic acid.Diabetes. 2018; 67: 1190-1199Crossref PubMed Scopus (44) Google Scholar, Ma et al., 2015Ma Y. Kind T. Vaniya A. Gennity I. Fahrmann J.F. Fiehn O. An in silico MS/MS library for automatic annotation of novel FAHFA lipids.J. Cheminform. 2015; 7: 53Crossref PubMed Scopus (56) Google Scholar, Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar, Zhang et al., 2016Zhang T. Chen S. Syed I. Ståhlman M. Kolar M.J. Homan E.A. Chu Q. Smith U. Borén J. Kahn B.B. Saghatelian A. A LC-MS-based workflow for measurement of branched fatty acid esters of hydroxy fatty acids.Nat. Protoc. 2016; 11: 747-763Crossref PubMed Scopus (53) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar) (Table S2) or more recently by an additional group (Zhu et al., 2018Zhu Q.F. Yan J.W. Zhang T.Y. Xiao H.M. Feng Y.Q. Comprehensive screening and identification of fatty acid esters of hydroxy fatty acids in plant tissues by chemical isotope labeling-assisted liquid chromatography-mass spectrometry.Anal. Chem. 2018; 90: 10056-10063Crossref PubMed Scopus (60) Google Scholar). Furthermore, no information is provided comparing their protocol to any of the reported procedures to validate their results. As a result, when Pflimlin et al. report that endogenous PAHSA levels are below the limit of quantitation in serum of mice fed the hydrogenated vegetable diet with which we detect quantifiable serum levels, it most likely reflects limitations in their methodology. We (Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar, Vijayakumar et al., 2017Vijayakumar A. Aryal P. Wen J. Syed I. Vazirani R.P. Moraes-Vieira P.M. Camporez J.P. Gallop M.R. Perry R.J. Peroni O.D. et al.Absence of carbohydrate response element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport.Cell Rep. 2017; 21: 1021-1035Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar) and others (Brezinova et al., 2018Brezinova M. Kuda O. Hansikova J. Rombaldova M. Balas L. Bardova K. Durand T. Rossmeisl M. Cerna M. Stranak Z. Kopecky J. Levels of palmitic acid ester of hydroxystearic acid (PAHSA) are reduced in the breast milk of obese mothers.Biochim. Biophys. Acta. 2018; 1863: 126-131Crossref PubMed Scopus (44) Google Scholar) also detect PAHSA levels in serum of chow-fed mice and some isomers are higher than in HFD-fed mice. In contrast, Pflimlin et al. found levels to be below the limit of detection in mice on several LFDs, including the chow diet we used. We are also puzzled by the Pflimlin et al. observation that administration of equivalent doses of 5-PAHSA or 9-PAHSA results in markedly higher 5-PAHSA levels in comparison to 9-PAHSA levels in serum (Table S2 in Pflimlin et al.). For example, oral gavage of an equivalent dose of 5- or 9-PAHSA resulted in 5-PAHSA concentration of 320 nM but a 9-PAHSA concentration of only 21 nM. Other conditions reported in this manuscript also result in a similarly disproportionate increase in 5-PAHSA over 9-PAHSA for equivalent doses. We have not performed these experiments under these conditions, but when we deliver equivalent doses of 5- and 9-PAHSA, we observe similar fold increases in serum levels of each PAHSA (Syed et al., 2017Syed I. Mohan J.F. Moraes-Vieria P.M. Vijayakumar A. De Celis M.F.R. Nelson A.T. Siegel D. Saghatelian A. Mathis D. Kahn B.B. PAHSAs reduce type 1 diabetes incidence in nonobese diabetic (NOD) mice through anti-inflammatory effects and direct protection against cytokine-induced islet β-cell death.Diabetes. 2017; 66: A87PubMed Google Scholar, Syed et al., 2018Syed I. Lee J. Moraes-Vieira P.M. Donaldson C.J. Sontheimer A. Aryal P. Wellenstein K. Kolar M.J. Nelson A.T. Siegel D. et al.Palmitic acid hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis.Cell Metab. 2018; 27: 419-427.e4Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). Previous reports from our group (Kolar et al., 2018Kolar M.J. Nelson A.T. Chang T. Ertunc M.E. Christy M.P. Ohlsson L. Härröd M. Kahn B.B. Siegel D. Saghatelian A. Faster protocol for endogenous fatty acid esters of hydroxy fatty acid (FAHFA) measurements.Anal. Chem. 2018; 90: 5358-5365Crossref PubMed Scopus (33) Google Scholar, Yore et al., 2014Yore M.M. Syed I. Moraes-Vieira P.M. Zhang T. Herman M.A. Homan E.A. Patel R.T. Lee J. Chen S. Peroni O.D. et al.Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.Cell. 2014; 159: 318-332Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar, Zhang et al., 2016Zhang T. Chen S. Syed I. Ståhlman M. Kolar M.J. Homan E.A. Chu Q. Smith U. Borén J. Kahn B.B. Saghatelian A. A LC-MS-based workflow for measurement of branched fatty acid esters of hydroxy fatty acids.Nat. Protoc. 2016; 11: 747-763Crossref PubMed Scopus (53) Google Scholar) and others (Brezinova et al., 2018Brezinova M. Kuda O. Hansikova J. Rombaldova M. Balas L. Bardova K. Durand T. Rossmeisl M. Cerna M. Stranak Z. Kopecky J. Levels of palmitic acid ester of hydroxystearic acid (PAHSA) are reduced in the breast milk of obese mothers.Biochim. Biophys. Acta. 2018; 1863: 126-131Crossref PubMed Scopus (44) Google Scholar) noted the possibility of a ceramide contaminant overlapping with 5-PAHSA, which could lead to artificially high estimates of 5-PAHSA. Therefore, we are concerned that the LC-MS protocols employed by Pflimlin et al. are overestimating 5-PAHSA and we strongly caution other groups not to use their protocol to measure serum or tissue PAHSA levels. In summary, Pflimlin et al. challenge our conclusion that PAHSAs improve glucose control in mice. Many important methodological issues contribute to the different results and several of these were discussed by Pflimlin et al. Most importantly, we demonstrate here that olive oil, a bioactive nutrient used by Pflimlin et al. as a vehicle, markedly improves glucose tolerance in HFD-fed mice (Figures S1B and S1C), which would mask effects of PAHSAs since constituents of olive oil signal through some of the same pathways as PAHSAs. Since vehicles used to formulate therapeutic agents are critical for compound bioavailability, efficacy, and safety (Strickley, 2004Strickley R.G. Solubilizing excipients in oral and injectable formulations.Pharm. Res. 2004; 21: 201-230Crossref PubMed Scopus (1161) Google Scholar), the choice of vehicles can determine whether a compound has therapeutic potential. Furthermore, it is important that other investigators not use the LC-MS protocol published by Pflimlin et al. since it has not been validated and it is likely to detect a contaminant(s). We thank Drs. Yan Zhu and Rucha Patel for technical assistance. The work described here is supported by NIH grants R01 DK43051, P30 DK57521 (B.B.K.), R01 DK106210 (B.B.K. and A. Saghatelian), and T32 DK07516 (B.B.K. and J.L.), and a grant from the JPB Foundation (B.B.K.). I.S., J.L., M.M.Y., P.M.M.-V., A. Saghatelian, and B.B.K. are inventors on patents related to the FAHFAs. Download .pdf (.62 MB) Help with pdf files Document S1. Figure S1 and Tables S1 and S2 Acute and Repeated Treatment with 5-PAHSA or 9-PAHSA Isomers Does Not Improve Glucose Control in MicePflimlin et al.Cell MetabolismJune 21, 2018In BriefPAHSAs were previously recognized as a new class of mammalian lipids. Pflimlin et al. report a novel chemical synthesis for PAHSAs. In contrast to earlier reports, Pflimlin et al. did not observe beneficial effects on glucose metabolism after acute or repeated PAHSA treatment using cellular systems or mouse models of insulin resistance. Full-Text PDF Open ArchiveOn the Complexity of PAHSA ResearchOndrej KudaCell MetabolismSeptember 20, 2018In BriefReporting in Cell Metabolism, Pflimlin et al. recently found no beneficial effect of PAHSAs on glucose control in mice on several high-fat diets. Kuda cautions that due to methodological differences, the data must be carefully reinterpreted, emphasizing that olive oil contains high amounts of FAHFAs, potentially masking the effects of PAHSAs in studies utilizing this vehicle. Full-Text PDF Open Archive" @default.
• W2890884829 created "2018-09-27" @default.
• W2890884829 creator A5001356701 @default.
• W2890884829 creator A5005649067 @default.
• W2890884829 creator A5011853620 @default.
• W2890884829 creator A5014345315 @default.
• W2890884829 creator A5021263351 @default.
• W2890884829 creator A5028599620 @default.
• W2890884829 creator A5044456069 @default.
• W2890884829 creator A5065981856 @default.
• W2890884829 creator A5077356039 @default.
• W2890884829 creator A5088314972 @default.
• W2890884829 creator A5088700296 @default.
• W2890884829 date "2018-10-01" @default.
• W2890884829 modified "2023-10-14" @default.
• W2890884829 title "Methodological Issues in Studying PAHSA Biology: Masking PAHSA Effects" @default.
• W2890884829 cites W1928460949 @default.
• W2890884829 cites W2062407245 @default.
• W2890884829 cites W2144417922 @default.
• W2890884829 cites W2152560090 @default.
• W2890884829 cites W2177511520 @default.
• W2890884829 cites W2300169074 @default.
• W2890884829 cites W2431383438 @default.
• W2890884829 cites W2509535979 @default.
• W2890884829 cites W2744470223 @default.
• W2890884829 cites W2765630251 @default.
• W2890884829 cites W2769398746 @default.
• W2890884829 cites W2785655120 @default.
• W2890884829 cites W2789777628 @default.
• W2890884829 cites W2793012188 @default.
• W2890884829 cites W2808925717 @default.
• W2890884829 cites W2884442495 @default.
• W2890884829 cites W2885547437 @default.
• W2890884829 doi "https://doi.org/10.1016/j.cmet.2018.09.007" @default.
• W2890884829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6542592" @default.
• W2890884829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30244974" @default.
• W2890884829 hasPublicationYear "2018" @default.
• W2890884829 type Work @default.
• W2890884829 sameAs 2890884829 @default.
• W2890884829 citedByCount "33" @default.
• W2890884829 countsByYear W28908848292019 @default.
• W2890884829 countsByYear W28908848292020 @default.
• W2890884829 countsByYear W28908848292021 @default.
• W2890884829 countsByYear W28908848292022 @default.
• W2890884829 countsByYear W28908848292023 @default.
• W2890884829 crossrefType "journal-article" @default.
• W2890884829 hasAuthorship W2890884829A5001356701 @default.
• W2890884829 hasAuthorship W2890884829A5005649067 @default.
• W2890884829 hasAuthorship W2890884829A5011853620 @default.
• W2890884829 hasAuthorship W2890884829A5014345315 @default.
• W2890884829 hasAuthorship W2890884829A5021263351 @default.
• W2890884829 hasAuthorship W2890884829A5028599620 @default.
• W2890884829 hasAuthorship W2890884829A5044456069 @default.
• W2890884829 hasAuthorship W2890884829A5065981856 @default.
• W2890884829 hasAuthorship W2890884829A5077356039 @default.
• W2890884829 hasAuthorship W2890884829A5088314972 @default.
• W2890884829 hasAuthorship W2890884829A5088700296 @default.
• W2890884829 hasBestOaLocation W28908848291 @default.
• W2890884829 hasConcept C127413603 @default.
• W2890884829 hasConcept C142362112 @default.
• W2890884829 hasConcept C153349607 @default.
• W2890884829 hasConcept C15744967 @default.
• W2890884829 hasConcept C169760540 @default.
• W2890884829 hasConcept C188147891 @default.
• W2890884829 hasConcept C2777402240 @default.
• W2890884829 hasConcept C41008148 @default.
• W2890884829 hasConcept C55587333 @default.
• W2890884829 hasConcept C70721500 @default.
• W2890884829 hasConcept C86803240 @default.
• W2890884829 hasConceptScore W2890884829C127413603 @default.
• W2890884829 hasConceptScore W2890884829C142362112 @default.
• W2890884829 hasConceptScore W2890884829C153349607 @default.
• W2890884829 hasConceptScore W2890884829C15744967 @default.
• W2890884829 hasConceptScore W2890884829C169760540 @default.
• W2890884829 hasConceptScore W2890884829C188147891 @default.
• W2890884829 hasConceptScore W2890884829C2777402240 @default.
• W2890884829 hasConceptScore W2890884829C41008148 @default.
• W2890884829 hasConceptScore W2890884829C55587333 @default.
• W2890884829 hasConceptScore W2890884829C70721500 @default.
• W2890884829 hasConceptScore W2890884829C86803240 @default.
• W2890884829 hasFunder F4320309814 @default.
• W2890884829 hasFunder F4320332161 @default.
• W2890884829 hasIssue "4" @default.
• W2890884829 hasLocation W28908848291 @default.
• W2890884829 hasLocation W28908848292 @default.
• W2890884829 hasLocation W28908848293 @default.
• W2890884829 hasLocation W28908848294 @default.
• W2890884829 hasOpenAccess W2890884829 @default.
• W2890884829 hasPrimaryLocation W28908848291 @default.
• W2890884829 hasRelatedWork W1517958729 @default.
• W2890884829 hasRelatedWork W1980230116 @default.
• W2890884829 hasRelatedWork W2002555665 @default.
• W2890884829 hasRelatedWork W2092272653 @default.
• W2890884829 hasRelatedWork W2170155919 @default.
• W2890884829 hasRelatedWork W2349444258 @default.
• W2890884829 hasRelatedWork W271627879 @default.
• W2890884829 hasRelatedWork W3081694532 @default.
• W2890884829 hasRelatedWork W3211357012 @default.

• next